Preprint · OA
via OpenAlex
Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases
Danielle L. Kirkman, Austin T. Robinson, Matthew J. Rossman, Douglas R. Seals, David G. Edwards
American Journal of Physiology-Heart and Circulatory Physiology · 2021 · ▲ 141 citations
Abstract
Cardiovascular disease (CVD) affects one in three adults and remains the leading cause of death in America. Advancing age is a major risk factor for CVD. Recent plateaus in CVD-related mortality rates in high-income countries after decades of decline highlight a critical need to identify novel therapeutic targets and strategies to mitigate and manage the risk of CVD development and progression. Vascular dysfunction, characterized by endothelial dysfunction and large elastic artery stiffening, is independently associated with an increased CVD risk and incidence and is therefore an attractive target for CVD prevention and management. Vascular mitochondria have emerged as an important player in maintaining vascular homeostasis. As such, age- and disease-related impairments in mitochondrial function contribute to vascular dysfunction and consequent increases in CVD risk. This review outlines the role of mitochondria in vascular function and discusses the ramifications of mitochondrial dysfunction(definition) on vascular health in the setting of age and disease. The adverse vascular consequences of increased mitochondrial-derived reactive oxygen species, impaired mitochondrial quality control, and defective mitochondrial calcium cycling are emphasized, in particular. Current evidence for both lifestyle and pharmaceutical mitochondrial-targeted strategies to improve vascular function is also presented.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1152/ajpheart.00917.2020
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Kirkman, D.L., Robinson, A.T., Rossman, M.J., Seals, D.R., & Edwards, D.G. (2021). Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases. <em>American Journal of Physiology-Heart and Circulatory Physiology</em>. https://doi.org/10.1152/ajpheart.00917.2020
Vancouver
Kirkman DL, Robinson AT, Rossman MJ, Seals DR, Edwards DG. Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases. American Journal of Physiology-Heart and Circulatory Physiology. 2021. doi:10.1152/ajpheart.00917.2020.
BibTeX
@unpublished{danielle2021Mitoch,
title = {Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases},
author = {Danielle L. Kirkman and Austin T. Robinson and Matthew J. Rossman and Douglas R. Seals and David G. Edwards},
journal = {American Journal of Physiology-Heart and Circulatory Physiology},
year = {2021},
doi = {10.1152/ajpheart.00917.2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CU Scholar (University of Colorado Boulder) 2012
Preprint · OA
Amelioration of Age-Related Vascular Dysfunction with SIRT1 Activation
International Journal of Molecular Sciences 2015
Open access · CC-BY
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction
University of Colorado, Boulder 2021
Open access · US-GOV
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Frontiers in Cell and Developmental Biology 2017
Open access · CC-BY
Interorganelle Communication between Mitochondria and the Endolysosomal System
Aging and Cancer 2021
Open access · CC-BY
Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
CU Scholar (University of Colorado Boulder) 2025
Preprint